CB Insights
Technology Market Intelligence
Technology Market Intelligence
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2019-05-22 | Allovir | Series B | $120M | EcoR1 Capital, Fidelity Investments, Gilead Sciences, Invus Group, Leerink Partners, Redmile Group, and Samsara BioCapital |
| 2019-05-13 | ElevateBio | Series A | $150M | EcoR1 Capital, MPM Capital, Redmile Group, and Samsara BioCapital |
| 2019-03-13 | TriNetX | Series D | $40M | Deerfield Management, ITOCHU Corporation, ITOCHU Technology Ventures, Merck Global Health Innovation Fund, Mitsui & Co., and MPM Capital |
| 2018-03-21 | TCR2 Therapeutics | Series B | $125M | 6 Dimensions Capital, Alexandria Venture Investments, ArrowMark Partners, Cathay Capital Private Equity, Curative Ventures, Haitong International, Hillhouse Capital Management, Leerink Partners, Mirae Asset Financial Group, MPM Capital, Redmile Group, Shandong Luxin Investment Holdings Group, Sirona Capital, and Syno Capital |
| 2017-10-03 | Cullinan Oncology | Series A | $150M | MPM Capital |
